SERUM SQUAMOUS CELL CARCINOMA ANTIGEN (SCCAG) LEVELS SHOULD BE USED IN CLINICAL DECISION MAKING FOR PATIENTS WITH EARLY-STAGE CERVICAL CARCINOMA. Issue 1 (1st March 2003) - Reesink-Peters, N.; van der Velden, K.; Duk, J. M.; ten Hoor, K. H.; Boezen, H. M.; de Bruijn, H. W.A.; Hollema, H.; van der Zee, A. G.J.